Literature DB >> 33552715

Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis.

Qian Zhao1, Yan Zhang1, Shichun Shao2, Yeqing Sun2, Zhengkui Lin1.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC), the main type of liver cancer in human, is one of the most prevalent and deadly malignancies in the world. The present study aimed to identify hub genes and key biological pathways by integrated bioinformatics analysis.
METHODS: A bioinformatics pipeline based on gene co-expression network (GCN) analysis was built to analyze the gene expression profile of HCC. Firstly, differentially expressed genes (DEGs) were identified and a GCN was constructed with Pearson correlation analysis. Then, the gene modules were identified with 3 different community detection algorithms, and the correlation analysis between gene modules and clinical indicators was performed. Moreover, we used the Search Tool for the Retrieval of Interacting Genes (STRING) database to construct a protein protein interaction (PPI) network of the key gene module, and we identified the hub genes using nine topology analysis algorithms based on this PPI network. Further, we used the Oncomine analysis, survival analysis, GEO data set and random forest algorithm to verify the important roles of hub genes in HCC. Lastly, we explored the methylation changes of hub genes using another GEO data (GSE73003).
RESULTS: Firstly, among the expression profiles, 4,130 up-regulated genes and 471 down-regulated genes were identified. Next, the multi-level algorithm which had the highest modularity divided the GCN into nine gene modules. Also, a key gene module (m1) was identified. The biological processes of GO enrichment of m1 mainly included the processes of mitosis and meiosis and the functions of catalytic and exodeoxyribonuclease activity. Besides, these genes were enriched in the cell cycle and mitotic pathway. Furthermore, we identified 11 hub genes, MCM3, TRMT6, AURKA, CDC20, TOP2A, ECT2, TK1, MCM2, FEN1, NCAPD2 and KPNA2 which played key roles in HCC. The results of multiple verification methods indicated that the 11 hub genes had highly diagnostic efficiencies to distinguish tumors from normal tissues. Lastly, the methylation changes of gene CDC20, TOP2A, TK1, FEN1 in HCC samples had statistical significance (P-value < 0.05).
CONCLUSION: MCM3, TRMT6, AURKA, CDC20, TOP2A, ECT2, TK1, MCM2, FEN1, NCAPD2 and KPNA2 could be potential biomarkers or therapeutic targets for HCC. Meanwhile, the metabolic pathway, the cell cycle and mitotic pathway might played vital roles in the progression of HCC. ©2021 Zhao et al.

Entities:  

Keywords:  Biological pathway; Gene co-expression network; Hepatocellular carcinoma; Hub gene

Year:  2021        PMID: 33552715      PMCID: PMC7821758          DOI: 10.7717/peerj.10594

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  56 in total

1.  Base-Resolution Mapping Reveals Distinct m1A Methylome in Nuclear- and Mitochondrial-Encoded Transcripts.

Authors:  Xiaoyu Li; Xushen Xiong; Meiling Zhang; Kun Wang; Ying Chen; Jun Zhou; Yuanhui Mao; Jia Lv; Danyang Yi; Xiao-Wei Chen; Chu Wang; Shu-Bing Qian; Chengqi Yi
Journal:  Mol Cell       Date:  2017-11-05       Impact factor: 17.970

2.  Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement.

Authors:  Hani Goodarzi; Xuhang Liu; Hoang C B Nguyen; Steven Zhang; Lisa Fish; Sohail F Tavazoie
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

Review 3.  Mechanisms, regulation and consequences of protein SUMOylation.

Authors:  Kevin A Wilkinson; Jeremy M Henley
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

4.  TOP2A amplification and overexpression in hepatocellular carcinoma tissues.

Authors:  Ravat Panvichian; Anchalee Tantiwetrueangdet; Napat Angkathunyakul; Surasak Leelaudomlipi
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

5.  cytoHubba: identifying hub objects and sub-networks from complex interactome.

Authors:  Chia-Hao Chin; Shu-Hwa Chen; Hsin-Hung Wu; Chin-Wen Ho; Ming-Tat Ko; Chung-Yen Lin
Journal:  BMC Syst Biol       Date:  2014-12-08

6.  Identification of aberrant tRNA-halves expression patterns in clear cell renal cell carcinoma.

Authors:  Malin Nientiedt; Mario Deng; Doris Schmidt; Sven Perner; Stefan C Müller; Jörg Ellinger
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

Review 7.  DNA hypermethylation in disease: mechanisms and clinical relevance.

Authors:  Melanie Ehrlich
Journal:  Epigenetics       Date:  2019-07-08       Impact factor: 4.528

8.  Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma.

Authors:  Chen Hao Jiang; Xin Yuan; Jiang Fen Li; Yu Fang Xie; An Zhi Zhang; Xue Li Wang; Lan Yang; Chun Xia Liu; Wei Hua Liang; Li Juan Pang; Hong Zou; Xiao Bin Cui; Xi Hua Shen; Yan Qi; Jin Fang Jiang; Wen Yi Gu; Feng Li; Jian Ming Hu
Journal:  J Transl Med       Date:  2020-01-30       Impact factor: 5.531

9.  DUXAP8 a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation.

Authors:  Chaosen Yue; Chaojie Liang; Pengyang Li; Lijun Yan; Dongxin Zhang; Yingchen Xu; Zhigang Wei; Jixiang Wu
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

10.  DNA methylation biomarkers for hepatocellular carcinoma.

Authors:  Guorun Fan; Yaqin Tu; Cai Chen; Haiying Sun; Chidan Wan; Xiong Cai
Journal:  Cancer Cell Int       Date:  2018-09-17       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.